Device Medical Device

(8944) Trilogy Evo Univ

Payments companies reported to CMS as associated with (8944) Trilogy Evo Univ. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$424associated payments (2023-2025)

16clinicians with associated payments

1company reporting

By year

2023 $424

Payments reported as associated with (8944) Trilogy Evo Univ, per program year, as reported to CMS.

Who makes it

Philips Electronics North America Corporation $424 associated with (8944) Trilogy Evo Univ (2023-2025)

Specialties most often involved

Internal Medicine $298

Sleep Medicine (Internal Medicine) $60.76

Pulmonary Disease $21.85

Family Medicine $21.56

Hospitalist $21.56

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with (8944) Trilogy Evo Univ

These are the largest totals companies reported as associated with (8944) Trilogy Evo Univ. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Nishay Chitkara	New York, NY	Internal Medicine	$60.76
Ridhwan Baba	New York, NY	Sleep Medicine (Internal Medicine)	$60.76
Gurmit Gill	Garden City, NY	Pulmonary Disease	$21.85
Tatyana Zagoruychenko	Brooklyn, NY	Hospitalist	$21.56
Muhammad Tahir	Brooklyn, NY	Family Medicine	$21.56
Mahreen Akram	Brooklyn, NY	Internal Medicine	$21.56
Anjula Gandhi	Brooklyn, NY	Internal Medicine	$21.56
Larisa Mararenko	Brooklyn, NY	Internal Medicine	$21.56
Alexa Kahn	Brooklyn, NY	Internal Medicine	$21.56
Halyna Mylko	Brooklyn, NY	Internal Medicine	$21.56

Prescribed (8944) Trilogy Evo Univ?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.